Press Releases

Date Title and Summary Additional Formats
Toggle Summary James Green Named President and CEO of Harvard Bioscience
HOLLISTON, Mass. , July 08, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that James Green has been named President and Chief Executive Officer of the Company by its Board of Directors, effective immediately. Additionally, Harvard Bioscience’s Board has appointed
View HTML
Toggle Summary Harvard Bioscience Subsidiary Data Sciences International Launches Hardware for Expanding Research Capabilities
Designed to Acquire and Synchronize Pre-clinical Signals from Disparate Sources ST. PAUL, Minn. and HOLLISTON, Mass. , June 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq: HBIO) and the global leader in wireless physiologic
View HTML
Toggle Summary Harvard Bioscience Subsidiary Data Sciences International Launches Digital Telemetry Implant for Measuring Respiratory Endpoints
Digital Telemetry Implant Saves Researchers Time and Money by Collecting More Data From One Implant ST. PAUL, Minn. and HOLLISTON, Mass. , May 15, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq: HBIO) and the global leader in wireless
View HTML
Toggle Summary Harvard Bioscience Reports First Quarter 2019 Financial Results
Reports both GAAP and adjusted non-GAAP revenue of $28.2 million, an increase of 5% and 2%, respectively HOLLISTON, Mass. , May 02, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), or the Company, a global developer, manufacturer and marketer of a broad range of solutions to
View HTML
Toggle Summary Harvard Bioscience Schedules First Quarter 2019 Conference Call for May 2 at 4:30 PM ET
HOLLISTON, Mass. , April 23, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2019 after market trading hours on Thursday, May 2, 2019 .
View HTML
Toggle Summary Harvard Bioscience Subsidiary Data Sciences International Wins Award for Best Achievement of Operational Excellence in Pharmaceuticals & Life Sciences
Company Receives Honor at Business Transformation & Operational Excellence Industry Awards 2019 in Orlando, Florida HOLLISTON, Mass. , April 03, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and
View HTML
Toggle Summary Harvard Bioscience To Showcase Products at Experimental Biology 2019
All Three Commercial Units to Be Represented HOLLISTON, Mass. , March 26, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting new laboratory products and applications for
View HTML
Toggle Summary Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance
-Reports record Fourth Quarter GAAP and adjusted non-GAAP revenue of $33.9 million, a year-over-year increase of 56% and 24%, respectively- HOLLISTON, Mass. , Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of
View HTML
Toggle Summary Harvard Bioscience Subsidiary Data Sciences International to Participate at SOT 2019 With Presentation and Exhibit
Company To Sponsor Session on Novel Approaches for Respiratory Measurement, Showcase Portfolio of Instrumentation Products and Solutions and Present Data HOLLISTON, Mass. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience , Inc. (Nasdaq: HBIO),
View HTML
Toggle Summary Harvard Bioscience Schedules Fourth Quarter 2018 Conference Call for February 28 at 4:30 PM ET
HOLLISTON, Mass. , Feb. 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2018 after market trading hours on Thursday, February 28,
View HTML